Replies to post #206240 on Innovation Pharmaceuticals Inc (IPIX)

[slcimmuno]

Could’ve fooled me — below just one of many many recent past posts of yours I could’ve referred to:

Themes include:

- Aspire wouldn’t come to Table... until they did ... and then when they did, you said it was a stupid move (toxic)

- Trials delayed and delayed and delayed... “whenever the Ph2s complete” (like this week prob?)

- No partners in sight (except today you say Partners possible, just like multiple P3s)

- Aruda dumping, though no proof of

- Fluff PRs... except when share price moves up

(and so forth — on and on and on)

So: how do you see the next 3, 6, 12 months playing out?

—————

Re: DaubersUP Post# 205265
Small OM trial took 2 plus years whats another 8 weeks? Last patient finished 58 days ago... Aspire loves the delays and projected partnerships pushed back time after time. On to 2018 we go with no cash to proceed phase 3 trials whenever the 2’s complete. When is UP phase 3 starting?
Replies:
What's next:Formal collaboration with pharmaceutical companies that have
Jhawker on 11/29/2017 9:29:30 PM
Leo does not have money to start any
Amatuer17 on 11/29/2017 11:08:59 PM

[sox040713]

I think “I’ve never doubted the science” contradicts “P and K are both question marks”. I agree that the stock should be over $5 if Leo can find a third party to validate the science.

I’ve never doubted the science. My problem has been the pump and dump of Absssi, the continued press release barrage revealing drawn out events. P and K are both question marks with OM the true hope for partnership. I’ve said the stock should trade above 5 but there needs to be validation of the science other than source Leo.